Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 8, 2008 - Issue 2
Submit an article Journal homepage
81
Views
5
CrossRef citations to date
0
Altmetric
Review

Therapies in development for castrate-resistant prostate cancer

Andrea L Harzstark Department of Medicine, University of California, San Francisco, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. [email protected]
&
Charles J Ryan Assistant Clinical Professor of Medicine, Department of Medicine, University of California, San Francisco, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. [email protected]
Pages 259-268 | Published online: 10 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

B. Alemayehu, E. Buysman, D. Parry, L. Becker & F. Nathan. (2010) Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population. Journal of Medical Economics 13:2, pages 351-361.
Read now

Articles from other publishers (4)

John Buscombe, Daniel Gillett, Nick Bird, Anne Powell, Sarah Heard & Luigi Aloj. (2022) Quantifying the survival benefit of completing all the six cycles of radium-223 therapy in patients with castrate-resistant prostate cancer with predominant bone metastases. World Journal of Nuclear Medicine 20:02, pages 139-144.
Crossref
Karim Fizazi, Cora N. Sternberg, John M. Fitzpatrick, R. William Watson & Majid Tabesh. (2010) Role of targeted therapy in the treatment of advanced prostate cancer. BJU International 105:6, pages 748-767.
Crossref
Hideaki Tahara, Marimo Sato, Magdalena Thurin, Ena Wang, Lisa H Butterfield, Mary L Disis, Bernard A Fox, Peter P Lee, Samir N Khleif, Jon M Wigginton, Stefan Ambs, Yasunori Akutsu, Damien Chaussabel, Yuichiro Doki, Oleg Eremin, Wolf Hervé Fridman, Yoshihiko Hirohashi, Kohzoh Imai, James Jacobson, Masahisa Jinushi, Akira Kanamoto, Mohammed Kashani-Sabet, Kazunori Kato, Yutaka Kawakami, John M Kirkwood, Thomas O Kleen, Paul V Lehmann, Lance Liotta, Michael T Lotze, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Hisahiro Matsubara, Shawmarie Mayrand-Chung, Kiminori Nakamura, Hiroyoshi Nishikawa, A Karolina Palucka, Emanuel F Petricoin, Zoltan Pos, Antoni Ribas, Licia Rivoltini, Noriyuki Sato, Hiroshi Shiku, Craig L Slingluff, Howard Streicher, David F Stroncek, Hiroya Takeuchi, Minoru Toyota, Hisashi Wada, Xifeng Wu, Julia Wulfkuhle, Tomonori Yaguchi, Benjamin Zeskind, Yingdong Zhao, Mai-Britt Zocca & Francesco M Marincola. (2009) Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology. Journal of Translational Medicine 7:1.
Crossref
Adam Heller. (2008) Apoptosis-Inducing High . NO Concentrations Are Not Sustained Either in Nascent or in Developed Cancers . ChemMedChem 3:10, pages 1493-1499.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.